CD8A and myeloid sarcoma: Quantitative changes in the CD57+CD8+ T-cell population are observed in different autoimmune diseases, such as MS [79,80], type 1 diabetes [76], Graves’ disease [77], ankylosing spondylitis [59], and rheumatoid arthritis [78,81].